On Sunday, 3,000 people took part in the 24th annual UMass Cancer Walk and Run, raising $700,000 for cancer trials at UMass Chan Medical School, according to a Tuesday press release.
Researchers at UMass Chan Medical School are teaming up with pharmaceutical giant Pfizer and the U.S. Food and Drug Administration to study the effects of the COVID-19 drug Paxlovid on patients aged 18 and under.